Read other letters about this article
Not quite up to the present. Ivins and co-workers from USAMRIID but also from HHS and FDA, were working at least since 2003 on a different type of anti-bioterrorism vaccine, one which would provide a temporary boost in a general way to the immune system, fending off a large array of different possible biological threats (they listed ebola, anthrax, smallpox, and others). The method could be used in combination with a traditional vaccine or without it.